ERBB2 and neoplasm: We observed that established predictors of worse prognosis (young age, tumor size exceeding 15 mm, high histological grade, more than three metastatic lymph nodes, ER-negative and HER2-positive status and high proliferative index) were associated with an increased risk of MC, in agreement with other studies [25, 27, 35–39].